Essential Partners’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3K Sell
1,629
-5,093
-76% -$25K ﹤0.01% 1201
2026
Q1
$23K Buy
6,722
+6,666
+11,904% +$22.5K 0.01% 872
2025
Q4
$158 Sell
56
-154
-73% -$794 ﹤0.01% 2473
2025
Q3
$1.46K Sell
210
-430
-67% -$3.03K ﹤0.01% 1900
2025
Q2
$3.79K Buy
+640
New +$3.68K ﹤0.01% 1133

Other funds holding ASPN

Essential Partners's ASPN Position: Q2 2026 in Review

Essential Partners reduced its Aspen Aerogels (ASPN) stake by 76% in Q2 2026, selling an estimated $25K and leaving 1,629 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1201.

Essential Partners first reported a position in ASPN in Q2 2025 and has held it in 5 quarters since. The position peaked at $23K in Q1 2026. 179 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Essential Partners held 1,629 shares of Aspen Aerogels worth $10.3K as of Q2 2026.
  • Essential Partners sold 5,093 Aspen Aerogels shares in Q2 2026, an estimated $25K.
  • Aspen Aerogels made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1201 holding.
  • Essential Partners first reported a position in Aspen Aerogels in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Aspen Aerogels position peaked at $23K in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.